Non-valvular atrial fibrillation in patients on peritoneal dialysis, prevalence, treatment and professionals involved.

Autor:	Perez-Bernat E; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, Valencia, Spain., Viñas MªA; Servicio de Urgencias, Hospital Universitari i Politecnic La Fe, Valencia, Spain., Vera M; Servicio de Nefrología, Hospital Clínic, Barcelona, Spain., González-Rico M; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, Valencia, Spain., Montomoli M; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, Valencia, Spain., Astudillo-Cortés E; Servicio de Nefrología, Hospital Universitario Central de Asturias, Oviedo, Spain., Quevedo-Reina JC; Servicio de Nefrología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas, Spain., García-Méndez I; Servicio de Nefrología, Hospital Josep Trueta, Girona, Spain., Martinez-Losa A; Servicio de Nefrología, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Rama-Arias I; Servicio de Nefrología, Hospital Univesitario de Bellvitge, Barcelona, Spain., Maldonado-Martín M; Servicio de Nefrología, Hospital Universitario La Paz, Madrid, Spain., Munar MªA; Servicio de Nefrología, Hospital Universitario Son Espases, Palma de Mallorca, Spain., Cerrato AO; Servicio de Nefrología, Complejo Hospitalario Universitario de Albacete, Albacete, Spain., Beltrán-Catalán S; Servicio de Nefrología, Hospital Universitario Dr Peset, Valencia, Spain., Peso GD; Servicio de Nefrología, Hospital Universitario La Paz, Madrid, Spain., Cases A; Servicio de Nefrología, Hospital Clínic, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address: acases@ub.edu., Górriz JL; Servicio de Nefrología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Universitat de València, Valencia, Spain.
Jazyk:	angličtina
Zdroj:	Nefrologia [Nefrologia (Engl Ed)] 2024 Mar-Apr; Vol. 44 (2), pp. 268-275. Date of Electronic Publication: 2024 Apr 11.
DOI:	10.1016/j.nefroe.2024.03.008
Abstrakt:	Atrial fibrillation is the most frequent chronic arrhythmia in patients with chronic kidney disease. Oral anticoagulation with vitamin K antagonists and now direct oral anticoagulants have been and are the fundamental pillars for the prevention of thromboembolic events. However, there are no randomized clinical trials on the risk-benefit profile of oral anticoagulation in patients with chronic kidney disease stage 5 on peritoneal dialysis and there is little evidence in the literature in this population. The objective of our study was to know the prevalence, treatment and professionals involved in the management of atrial fibrillation in peritoneal dialysis patients. For this purpose, we performed a descriptive analysis through a survey sent to different peritoneal dialysis units in Spain. A total of 1,403 patients on peritoneal dialysis were included in the study, of whom 186 (13.2%) had non-valvular atrial fibrillation. In addition, the assessment of the scores of thromboembolic and bleeding risks for the indication of oral anticoagulation was mainly carried out by the cardiologist (60% of the units), as well as its prescription (cardiologist 47% or in consensus with the nephrologist 43%). In summary, patients on peritoneal dialysis have a remarkable prevalence of non-valvular atrial fibrillation. Patients frequently receive oral anticoagulation with vitamin K antagonists, as well as direct oral anticoagulants. The data obtained regarding the scores used for the assessment of thromboembolic and bleeding risk, treatment and involvement by Nephrology indicates that there is a need for training and involvement of the nephrologist in this pathology. (Copyright © 2024. Published by Elsevier España, S.L.U.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu